Skip to main content
. 2016 Aug 5;7(36):57841–57850. doi: 10.18632/oncotarget.11069

Table 1. Mouse models used in this study.

Mouse models Genotypes Background References
K14 HPV-8* K14 HPV-8 C57/Bl6 [16]
K14 HPV-8/K14 N17Rac1 K14 HPV-8; K14 N17Rac1 C57/Bl6 [16, 17]
K14 HPV-8 K14 HPV-8 FVB/N [16]
K14 L61Rac1 K14 L61Rac1 FVB/N [19]
K14 HPV-8/ K14 L61Rac1 K14 HPV-8; K14 L61Rac1 FVB/N [16, 19]
K14 HPV-8/ Rac1-EKO K14 HPV-8; K14 Cre; Rac1 fl/fl FVB/N [1618]
K14 HPV-8/ Rac1-EKOhet K14 HPV-8; K14 Cre; Rac1 fl/+ FVB/N [1618]
*

K14 HPV-8 mice in C57/Bl6 background were used as controls with K14 HPV-8/K14 N17Rac1 mice in C57/Bl6 background. All other mice were used in FVB/N background.

K14 HPV-8: complete early region of HPV-8 expressed under the control of K14 promoter. K14 N17Rac1: Dominant negative mutant of Rac1 expressed under the control of K14 promoter. K14 L61Rac1: Constitutively active mutant of Rac1 expressed under the control of K14 promoter. Rac1-EKO and Rac1-EKOhet: Cre recombinase expressed under the control of K14 promoter with two floxed alleles of Rac1 (Rac1-EKO) or one floxed allele and one wild type allele (Rac1-EKOhet).